Title: 
Official Title: To amend the Federal Food, Drug, and Cosmetic Act with respect to approval
            of abbreviated new drug applications.
Number of Sections: 2
Source: versions - Introduced in Senate
Media Type: text/xml

================================================================================

Section 1:
1.
            Short title
 This Act may be cited as the Reforming Evergreening and Manipulation that Extends Drug Years Act or the REMEDY Act.

Section 2:
2.
            Amendments to ANDA approval provisions
 Section 505 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355) is amended—
            
                (1)
 in subsection (c)(2) by adding at the end the following: With respect to a drug approved on or after the date of enactment of the Reforming Evergreening and Manipulation that Extends Drug Years Act, when a holder of an approved application first files information under this paragraph with respect to one or more patents described in subsection (b)(1)(A)(viii), the holder shall select one such patent with respect to which the owner or licensee may be eligible for the thirty-month period under paragraph (3)(C) or subsection (j)(5)(B)(iii), as applicable; for purposes of paragraphs (3)(C) and (3)(E)(ii) and subsections (j)(5)(B)(iii) and (j)(5)(F)(ii), such patent shall be referred to as the covered patent. The selection of such covered patent may not be changed or amended.;
            
            
                (2)
 in subsection (c)(3)(C)—  (A) in the matter preceding clause (i)—
                    
                        (i)
 by striking an action is brought for infringement and all that follows through the period at the end of the first sentence and inserting with respect to a drug approved under this subsection before the date of enactment of the Reforming Evergreening and Manipulation that Extends Drug Years Act, an action is brought for infringement of any patent that is the subject of the certification and for which information was submitted to the Secretary under paragraph (2) before the date on which the application (excluding an amendment or supplement to the application) was submitted, or, with respect to a drug approved under this subsection on or after the date of enactment of the Reforming Evergreening and Manipulation that Extends Drug Years Act, an action is brought for infringement of the covered patent (as described in paragraph (2)) that is the subject of the certification and for which information was submitted to the Secretary under paragraph (2) before the date on which the application (excluding an amendment or supplement to the application) was submitted.; and
                    
                    
                        (ii)
 by striking an action is brought before and inserting an action with respect to a patent or a covered patent, as applicable, is brought before; and
                    
                
                
                    (B)
 in clause (i), by striking decides that the patent and inserting decides that the patent or the covered patent, as applicable;
                
            
            
                (3)
 in the second sentence of subsection (c)(3)(E)(ii), by inserting with respect to any patent for which the requirements are met for the thirty-month period described in subparagraph (C) after action for patent infringement;
            
            
                (4)
 in subsection (j)(5)(B)(iii)—  (A) in the matter preceding subclause (I)—
                    
                        (i)
 by striking an action is brought for infringement and all that follows through the period at the end of the first sentence and inserting with respect to a drug approved under subsection (c) before the date of enactment of the Reforming Evergreening and Manipulation that Extends Drug Years Act, an action is brought for infringement of any patent that is the subject of the certification and for which information was submitted to the Secretary under subsection (c)(2) before the date on which the application (excluding an amendment or supplement to the application), which the Secretary later determines to be substantially complete, was submitted, or, with respect to a drug approved under subsection (c) on or after the date of enactment of the Reforming Evergreening and Manipulation that Extends Drug Years Act, an action is brought for infringement of the covered patent (as described in subsection (c)(2)) that is the subject of the certification and for which information was submitted to the Secretary under subsection (c)(2) before the date on which the application (excluding an amendment or supplement to the application), which the Secretary later determines to be substantially complete, was submitted.; and
                    
                    
                        (ii)
 by striking an action is brought before and inserting an action with respect to a patent or a covered patent, as applicable, is brought before; and
                    
                
                
                    (B)
 in subclause (I), by striking decides that the patent and inserting decides that the patent or covered patent, as applicable,; and
                
            
            
                (5)
 in the second sentence of subsection (j)(5)(F)(ii), by inserting with respect to any patent for which the requirements are met for the thirty-month period described in subparagraph (B)(iii), after action for patent infringement.


================================================================================

Raw Text:
119 S2620 IS: Reforming Evergreening and Manipulation that Extends Drug Years Act
U.S. Senate
2025-07-31
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.



        II
        119th CONGRESS
        1st Session
        S. 2620
        IN THE SENATE OF THE UNITED STATES
        
            July 31, 2025
            Mr. Durbin (for himself and Mr. Cassidy) introduced the following bill; which was
                read twice and referred to the Committee on
                    Health, Education, Labor, and Pensions
        
        A BILL
        To amend the Federal Food, Drug, and Cosmetic Act with respect to approval
            of abbreviated new drug applications.
    
    
        
            1.
            Short title
 This Act may be cited as the Reforming Evergreening and Manipulation that Extends Drug Years Act or the REMEDY Act.
        
        
            2.
            Amendments to ANDA approval provisions
 Section 505 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355) is amended—
            
                (1)
 in subsection (c)(2) by adding at the end the following: With respect to a drug approved on or after the date of enactment of the Reforming Evergreening and Manipulation that Extends Drug Years Act, when a holder of an approved application first files information under this paragraph with respect to one or more patents described in subsection (b)(1)(A)(viii), the holder shall select one such patent with respect to which the owner or licensee may be eligible for the thirty-month period under paragraph (3)(C) or subsection (j)(5)(B)(iii), as applicable; for purposes of paragraphs (3)(C) and (3)(E)(ii) and subsections (j)(5)(B)(iii) and (j)(5)(F)(ii), such patent shall be referred to as the covered patent. The selection of such covered patent may not be changed or amended.;
            
            
                (2)
 in subsection (c)(3)(C)—  (A) in the matter preceding clause (i)—
                    
                        (i)
 by striking an action is brought for infringement and all that follows through the period at the end of the first sentence and inserting with respect to a drug approved under this subsection before the date of enactment of the Reforming Evergreening and Manipulation that Extends Drug Years Act, an action is brought for infringement of any patent that is the subject of the certification and for which information was submitted to the Secretary under paragraph (2) before the date on which the application (excluding an amendment or supplement to the application) was submitted, or, with respect to a drug approved under this subsection on or after the date of enactment of the Reforming Evergreening and Manipulation that Extends Drug Years Act, an action is brought for infringement of the covered patent (as described in paragraph (2)) that is the subject of the certification and for which information was submitted to the Secretary under paragraph (2) before the date on which the application (excluding an amendment or supplement to the application) was submitted.; and
                    
                    
                        (ii)
 by striking an action is brought before and inserting an action with respect to a patent or a covered patent, as applicable, is brought before; and
                    
                
                
                    (B)
 in clause (i), by striking decides that the patent and inserting decides that the patent or the covered patent, as applicable;
                
            
            
                (3)
 in the second sentence of subsection (c)(3)(E)(ii), by inserting with respect to any patent for which the requirements are met for the thirty-month period described in subparagraph (C) after action for patent infringement;
            
            
                (4)
 in subsection (j)(5)(B)(iii)—  (A) in the matter preceding subclause (I)—
                    
                        (i)
 by striking an action is brought for infringement and all that follows through the period at the end of the first sentence and inserting with respect to a drug approved under subsection (c) before the date of enactment of the Reforming Evergreening and Manipulation that Extends Drug Years Act, an action is brought for infringement of any patent that is the subject of the certification and for which information was submitted to the Secretary under subsection (c)(2) before the date on which the application (excluding an amendment or supplement to the application), which the Secretary later determines to be substantially complete, was submitted, or, with respect to a drug approved under subsection (c) on or after the date of enactment of the Reforming Evergreening and Manipulation that Extends Drug Years Act, an action is brought for infringement of the covered patent (as described in subsection (c)(2)) that is the subject of the certification and for which information was submitted to the Secretary under subsection (c)(2) before the date on which the application (excluding an amendment or supplement to the application), which the Secretary later determines to be substantially complete, was submitted.; and
                    
                    
                        (ii)
 by striking an action is brought before and inserting an action with respect to a patent or a covered patent, as applicable, is brought before; and
                    
                
                
                    (B)
 in subclause (I), by striking decides that the patent and inserting decides that the patent or covered patent, as applicable,; and
                
            
            
                (5)
 in the second sentence of subsection (j)(5)(F)(ii), by inserting with respect to any patent for which the requirements are met for the thirty-month period described in subparagraph (B)(iii), after action for patent infringement.